基本信息
出版地:UNITED STATES
期刊简称:CARDIOVASC THER
通讯地址:WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148
创刊年份:2008
发行周期:Quarterly
涉及方向:医学 - 心血管系统
ESSN:1755-5922
英文期刊简介
Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology are also encouraged.
Subject areas include (but are by no means limited to):
Acute coronary syndrome
Arrhythmias
Atherosclerosis
Basic cardiac electrophysiology
Cardiac catheterization
Cardiac remodeling
Coagulation and thrombosis
Diabetic cardiovascular disease
Heart failure (systolic HF, HFrEF, diastolic HF, HFpEF)
Hyperlipidemia
Hypertension
Ischemic heart disease
Vascular biology
Ventricular assist devices
Molecular cardio-biology
Myocardial regeneration
Lipoprotein metabolism
Radial artery access
Percutaneous coronary intervention
Transcatheter aortic and mitral valve replacement.
中文期刊简介
《Cardiovascular Therapeutics》是一本由WILEY-HINDAWI出版商出版的专业医学期刊，该刊创刊于2008年，刊期Quarterly，该刊已被国际权威数据库SCI、SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 4区，小类学科：心脏和心血管系统 4区；药学 4区；在JCR（Journal Citation Reports）分区等级为Q2。该刊发文范围涵盖心脏和心血管系统等领域，旨在及时、准确、全面地报道国内外心脏和心血管系统工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为3.368，平均审稿速度平均6月。
